Bayer Equity 2024

Bayer Equity

32.93 B EUR

Bayer Dividend yield

8.9 %

Ticker

BAYN.DE

ISIN

DE000BAY0017

WKN

BAY001

In 2024, Bayer's equity was 32.93 B EUR, a -15.08% increase from the 38.77 B EUR equity in the previous year.

Bayer Aktienanalyse

What does Bayer do?

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain. Bayer ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Bayer revenue by segment

In the annual report of the Bayer share (DE000BAY0017, BAY001, BAYN.DE), it breaks down its revenues into 4 segments: 1. Pharmaceuticals, 2. Consumer Health, 3. All Other Segments, 4. Crop Science. The Bayer stock (WKN: BAY001, ISIN: DE000BAY0017, Ticker Symbol: BAYN.DE) is a leading investment for investors interested in participating in the Health Care sector.

Equity Details

Analyzing Bayer's Equity

Bayer's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bayer's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bayer's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bayer's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bayer’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bayer Stock

What is the equity of Bayer this year?

Bayer has equity of 32.93 B EUR this year.

What was the equity of Bayer compared to the previous year?

The equity of Bayer has increased/decreased by -15.08% decreased compared to the previous year.

What impact does a high equity have on investors of Bayer?

A high equity is advantageous for investors of Bayer as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bayer?

A low equity can be a risk for investors of Bayer, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bayer affect the company?

An increase in equity of Bayer can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bayer affect the company?

A reduction in equity of Bayer can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bayer?

Some factors that can affect the equity of Bayer include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bayer so important for investors?

The equity of Bayer is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bayer take to change the equity?

To change equity, Bayer can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bayer pay?

Over the past 12 months, Bayer paid a dividend of 2.4 EUR . This corresponds to a dividend yield of about 8.9 %. For the coming 12 months, Bayer is expected to pay a dividend of 2.43 EUR.

What is the dividend yield of Bayer?

The current dividend yield of Bayer is 8.9 %.

When does Bayer pay dividends?

Bayer pays a quarterly dividend. This is distributed in the months of May, June, June, May.

How secure is the dividend of Bayer?

Bayer paid dividends every year for the past 26 years.

What is the dividend of Bayer?

For the upcoming 12 months, dividends amounting to 2.43 EUR are expected. This corresponds to a dividend yield of 9 %.

In which sector is Bayer located?

Bayer is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bayer kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bayer from 5/2/2024 amounting to 0.11 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Bayer pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Bayer in the year 2023?

In the year 2023, Bayer distributed 2 EUR as dividends.

In which currency does Bayer pay out the dividend?

The dividends of Bayer are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bayer stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Bayer

Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.